Apellis' Empaveli Poised To Give Soliris A Run In PNH

New Drug Reaches The Market With Broad Label And Competitive Pricing

 
• By Jessica Merrill
  
Big dog and little dog
Apellis is a new entrant looking to compete against an entrenched rival • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip